• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An investigation of new infrared nonlinear optical material: BaCdSnSe4, and three new related centrosymmetric compounds: Ba2SnSe4, Mg2GeSe4, and Ba2Ge2S6?
  Kui Wu,Zhihua Yang,Shilie Pan Dalton Trans., 2015,44, 19856-19864
• 3. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An intramolecular tryptophan-condensation approach for peptide stapling?
  Eunice Y.-L. Hui,Bhimsen Rout,Yaw Sing Tan,Kok-Ping Chan,Charles W. Johannes Org. Biomol. Chem., 2018,16, 389-392

Professional Introduction to 1-(Methylamino)acetone Hydrochloride (CAS No. 97564-73-3)

1-(Methylamino)acetone hydrochloride, with the chemical formula C?H??NO·HCl, is a significant compound in the field of pharmaceutical and biochemical research. This compound has garnered considerable attention due to its versatile applications in drug synthesis and molecular biology studies. Its unique structural properties make it a valuable intermediate in the development of various therapeutic agents.

The compound is characterized by a hydrochloride salt form, which enhances its solubility in aqueous solutions, making it particularly useful in biochemical assays and drug formulations. The presence of both amine and ketone functional groups in its molecular structure allows for diverse chemical modifications, enabling researchers to tailor its properties for specific applications.

In recent years, 1-(methylamino)acetone hydrochloride has been extensively studied for its potential role in the synthesis of bioactive molecules. One of the most notable areas of research involves its use as a precursor in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By designing molecules that specifically inhibit kinase activity, researchers aim to develop novel therapeutic strategies.

Recent studies have demonstrated the efficacy of derivatives of 1-(methylamino)acetone hydrochloride in inhibiting specific kinases. For instance, modifications to the compound's structure have led to the development of potent inhibitors targeting tyrosine kinases, which are involved in tumor growth and metastasis. These findings highlight the compound's potential as a scaffold for anticancer drug development.

Beyond its applications in oncology, 1-(methylamino)acetone hydrochloride has also been explored in the field of neurology. Research suggests that certain derivatives of this compound may have neuroprotective properties, making them promising candidates for treating neurodegenerative diseases such as Alzheimer's and Parkinson's. The ability to modulate neurotransmitter systems and protect against oxidative stress makes this compound an attractive option for further investigation.

The synthesis of 1-(methylamino)acetone hydrochloride involves well-established organic chemistry techniques, including condensation reactions and acid-base neutralization. The process typically begins with the reaction of acetone with methylamine, followed by conversion to the hydrochloride salt to improve stability and handling properties. Advances in synthetic methodologies have enabled more efficient and scalable production methods, facilitating its use in large-scale research and industrial applications.

In addition to its pharmaceutical applications, 1-(methylamino)acetone hydrochloride has found utility in biochemical research as a tool for studying enzyme mechanisms and interactions. Its structural flexibility allows researchers to design analogs that can probe specific aspects of enzyme function. For example, site-directed mutagenesis studies using this compound have provided insights into the active sites of various enzymes, contributing to a better understanding of metabolic pathways.

The compound's solubility profile also makes it suitable for use in high-throughput screening (HTS) assays. HTS platforms are widely used in drug discovery to rapidly identify compounds with desired biological activities. By incorporating 1-(methylamino)acetone hydrochloride or its derivatives into these assays, researchers can efficiently screen large libraries of compounds for potential therapeutic candidates.

Ethical considerations are paramount when conducting research involving 1-(methylamino)acetone hydrochloride. While the compound itself is not classified as a controlled substance or hazardous material, proper handling procedures must be followed to ensure safety and compliance with regulatory standards. This includes using appropriate personal protective equipment (PPE) and working in well-ventilated areas or fume hoods.

The future prospects for 1-(methylamino)acetone hydrochloride appear promising, with ongoing research aimed at expanding its applications and understanding its mechanisms of action. As our knowledge of biological systems continues to grow, new opportunities are likely to emerge for this versatile compound. Collaborative efforts between academia and industry will be crucial in translating laboratory findings into tangible benefits for patients worldwide.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)